The Urticaria Control Test 7 (UCT7)
The Urticaria Control Test 7 (UCT7)
Couldn't load pickup availability
Description
The Urticaria Control Test 7 (UCT7) is a validated, easy to use questionnaire to determine disease control in patients with chronic urticaria of all subforms (spontaneous and inducible). The UCT7 is designed as a retrospective instrument and may be applied and evaluated quickly and easily during patient consultations.
The UCT7 is based on the Urticaria Control Test (UCT), which was developed by a Charité team of scientists led by Dr. Thomas Buttgereit, Dr. Karsten Weller and Dr. Marcus Maurer. Unlike the UCT, which assesses disease control in the past 4 weeks, the UCT7 measures disease control in the past 7 days.
Quick Facts UCT7:
Number of items: 4
Suited for: Adults (≥18 years old) with chronic urticaria of all subforms (spontaneous and inducible)
Assessment: retrospectively (recall period: 4 weeks)
Scoring: easy sum scoring, scoring template available
Cutoff-value: 12 points (<12 points indicate poorly controlled urticaria)
Copyright: Moxie GmbH (www.moxie-gmbh.de)
Terms of use: Free for routine clinical use and non-commercial research, fee for use in clinical trials/commercial research
Reference:
Buttgereit T, Salameh P, Sydorenko O, Zuberbier T, Metz M, Weller K, Maurer M. The 7-day recall period version of the Urticaria Control Test-UCT7. J Allergy Clin Immunol. 2023 May 18:S0091-6749(23)00604-8. doi: 10.1016/j.jaci.2023.03.034. Epub ahead of print. PMID: 37210040.
Commercial or non-commercial
If you are interested or on request, we will be happy to send you our PROMs (Patient Reported Outcomes Measures) on the various topics by e-mail.
Please understand that we have to charge a fee of 15 Euro per PRO when using our PROMs for commercial purposes. Commercial use include, for example, use in industry-sponsored studies, market research and similar purposes.
By non-commercial use we mean e.g. use for consultation hours in hospitals and private practices, use within scientific studies without sponsoring. The prerequisite is that no commercial interest is pursued.
Frequently Asked Questions
Why are there PRO (Patient Reported Outcomes) products that cost nothing and others that cost 15 Euros?
If you plan to use PRO (Patient Reported Outcomes) products (e.g. AAS, AE-QoL, UCT) commercially, there is a small fee per patient (15 €). This applies, for example, to industry-sponsored trials and clinical studies or market research.
You can order free versions, if you plan to use them for non commercial purposes, e.g. for patient management or for academia-driven non commercial
research projects. When you order PRO (Patient Reported Outcomes) products, these instruments are sent per e-mail.
I would like to use PRO (Patient Reported Outcomes) products commercially. Do I have to buy one version each for every time I plan to use it, even in the same patient?
No. Each PRO (Patient Reported Outcomes) products you purchase can be used multiple time by the same patient.
What do I do if PRO (Patient Reported Outcomes) products are not available for my country or in the language I need?
The version you are looking for is probably already under development. Feel free to get in touch with us by e-mail to check when it will be available.